DiaMedica Therapeutics (DMAC) Shares Outstanding (Weighted Average): 2018-2019

Historic Shares Outstanding (Weighted Average) for DiaMedica Therapeutics (DMAC) over the last 2 years, with Dec 2019 value amounting to $14.1 million.

  • DiaMedica Therapeutics' Shares Outstanding (Weighted Average) rose 18.25% to $14.1 million in Q4 2019 from the same period last year, while for Sep 2019 it was $12.0 million, marking a year-over-year increase of 1.42%. This contributed to the annual value of $42.9 million for FY2024, which is 12.92% up from last year.
  • DiaMedica Therapeutics' Shares Outstanding (Weighted Average) amounted to $14.1 million in Q4 2019, which was up 17.76% from $12.0 million recorded in Q3 2019.
  • Over the past 5 years, DiaMedica Therapeutics' Shares Outstanding (Weighted Average) peaked at $14.1 million during Q4 2019, and registered a low of $11.8 million during Q1 2018.
  • For the 2-year period, DiaMedica Therapeutics' Shares Outstanding (Weighted Average) averaged around $12.2 million, with its median value being $12.0 million (2019).
  • Data for DiaMedica Therapeutics' Shares Outstanding (Weighted Average) shows a peak YoY rose of 18.25% (in 2019) over the last 5 years.
  • Over the past 2 years, DiaMedica Therapeutics' Shares Outstanding (Weighted Average) (Quarterly) stood at $12.0 million in 2018, then climbed by 18.25% to $14.1 million in 2019.
  • Its last three reported values are $14.1 million in Q4 2019, $12.0 million for Q3 2019, and $12.0 million during Q2 2019.